RADIOPHARMACEUTICALS FOR IMAGING OF HYPOXIC TUMORS: A REVIEW
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2012, Vol 3, Issue 11
Abstract
Radiopharmaceuticals are drugs containing a radionuclide and are used routinely in nuclear medicine for the diagnosis and therapy of various diseases. The mechanism of localization of the radiopharmaceutical in different organs provides the clue for designing of the agent meant for a specific organ or pathway. Various agent like F-18, Cu-64/67, I-123, and Tc-99m are used as imaging of hypoxic tumors. Of these, F-18-fluoromisonidazole and I-123-iodoazomycin arabinoside (IAZA) have been most widely studied clinically. Non-nitro-containing bioreductive complexes, such as the Cu-60/62/64 thiosemicarbazone ATSM and Tc-99m butylene amineoxime (BnAO or HL91), have also been evaluated. In particular, I-123-IAZA and Cu-60-ATSM have shown correlation with response to radiotherapy in preliminary clinical studies. However, more preclinical studies comparing imaging with validated invasive methods and clinical studies with outcome measures are required. Nuclear medicine is poised to play an important role in optimizing the therapy of patients with hypoxic tumors. The present review is concern with the various radiopharmaceuticals used for imaging of hypoxia.
Authors and Affiliations
Chaitanya Prasad , Prasanna Sethy
Keywords
Related Articles
- EP ID EP92952
- DOI -
- Views 94
- Downloads 0
LIPOSOME AS A POTENTIAL DRUG DELIVERY SYSTEM: A REVIEW
Liposomes are microscopic phospholipid vescicles made of lipid bilayer which are the drug carrier for improving the delivery of therapeutic agents. Research on liposome technology has progressed from conventional v...
STUDY ON ENDOCRINOLOGICAL PROFILE OF HIV INFECTED MALE PATIENTS FROM EASTERN INDIA
Human Immunodeficiency virus (HIV) infectionis associated with a variety of endocrine problems. Hypoadrenalism, hypothyroidism and hypogonadism are commonly found singly or in combination. Especially, male hypogonadism i...
FINDING NEW INHIBITORS FOR EML4-ALK FUSION PROTEIN: A COMPUTATIONAL APPROACH
The fusion between echinoderm microtubule-associated protein-like 4 (EML4) and anaplastic lymphoma kinase (ALK) has recently been identified in a subset of non-small cell lung cancers (NSCLC). PF-02341066 (crizotinib) is...
ANTIOXIDANT, CYTOTOXIC PROPERTIES AND PHYTOCHEMICAL SCREENING OF TWO LEBANESE MEDICINAL PLANTS
Nowadays herbal medicine presents a significant adjuvant tool for hard treatment, especially in the case of cancer where modern medicine has access to traditional medicine to deprive the patient of the side effects of th...
PHYTOCHEMICAL CHARACTERIZATION OF AN ENDEMIC PLANT USED AS FOODSTUFF IN TURKEY: CENTAUREA URVILLEI SUBSP. STEPPOSA AND ITS ANTIOXIDANT PROPERTIES
This study was focused on the analysis of the phenolic content, fatty acid composition, volatile compounds and antioxidant activity of methanol extract from Centaurea urvillei subsp. stepposa. The antioxidant capacity we...